CLINICAL_TRIALS
trial_result
· 2025-11-12
Clinical Trial Update: Optimal Treatment for Recurrent Clostridium Difficile [Phase 4]
Summary
Phase 4 trial evaluating optimal treatment for recurrent Clostridioides difficile infection has terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Clostridium, Difficile | Phase 4 | Status: TERMINATED | Results posted: 2025-11-12